Avalo Therapeutics
AVTX
AVTX
84 hedge funds and large institutions have $361M invested in Avalo Therapeutics in 2025 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 28 increasing their positions, 13 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
27% more funds holding
Funds holding: 66 → 84 (+18)
6.8% less ownership
Funds ownership: 116.46% → 109.66% (-6.8%)
Holders
84
Holding in Top 10
–
Calls
$6.05M
Puts
$3.35M
Top Buyers
| 1 | +$8.82M | |
| 2 | +$8.03M | |
| 3 | +$7.62M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$7.46M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$7.3M |
Top Sellers
| 1 | -$7.2M | |
| 2 | -$6.38M | |
| 3 | -$3.32M | |
| 4 |
O
OrbiMed
New York
|
-$2.73M |
| 5 |
ABG
Ally Bridge Group
New York
|
-$2.26M |
